Racial Variation in Antidepressant Treatment in a Medicaid Population
J Clin Psychiatry 2000;61:16-21
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: Many studies have found racial and
socioeconomic variation in medical care for a variety of
conditions. Undertreatment of depression for individuals of all
races is a concern, but especially may affect vulnerable
populations such as Medicaid recipients and minorities. With this
study, we examine racial differences in the antidepressant usage
in a Medicaid population.
Method: Treatment of 13,065 depressed patients
(ICD-9-CM criteria) was examined in a state Medicaid database
covering the years 1989 through 1994. Treatment differences were
assessed in terms of whether an antidepressant was received at
the time of the initial depression diagnosis and the type of
antidepressant prescribed (tricyclic antidepressants [TCAs] vs.
selective serotonin reuptake inhibitors [SSRIs]), using logistic
Results: African Americans were less likely than
whites to receive an antidepressant at the time of their initial
depression diagnosis (27.2% vs. 44.0%, p < .001). Of those
receiving an antidepressant, whites were more likely than African
Americans to receive SSRIs versus TCAs. These findings remained
even after adjusting for other covariates.
Conclusion: Despite the easy availability of
effective treatments, we found that only a small portion of
depressed Medicaid recipients receive adequate usage of
antidepressants. Within this Medicaid population, limited access
to treatment was especially pronounced among African Americans.
Racial differences existed in terms of whether an antidepressant
was received and the type of medication used.